In a feeding study involving 45 healthy subjects, the mean conversion rate of glucosinolates (of which 85% was glucoraphanin) to dithiocarbamates over a 24-hour period was estimated to be around 12% with wide variations among participants (range, 1.1 to 40.7%) (6)
Both contain the same active ingredient, but compounded semaglutide from licensed 503A pharmacies offers personalized dosing and flexible escalation schedules
If approved, orforglipron could become one of the next major entrants in the growing GLP-1 pill market, offering patients and clinicians another option in the evolving treatment landscape
Search Strategy and Selection Criteria Data for this Review were identified by searches of MEDLINE, Current Contents, PubMed, and references from relevant articles using the search terms GLP-1, cardiovascular, neurological, endocrine and cancer